GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Acutaas Chemicals Ltd

Acutaas Chemicals Q2 FY27 Standalone Net Profit at Rs. 8,573.85 Lakhs

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 27 Oct 2026, 12:46 PM IST  ·  BSE ID: b21c3756-7015-4618-a049-d4528a46a473
View Original BSE Filing (PDF)
💡
In Simple Terms
Acutaas Chemicals reported increased standalone net profit for the second quarter and first half of FY27.
🤖 AI Summary
  • Acutaas Chemicals reported Q2 FY27 standalone net profit of Rs. 8,573.85 Lakhs, up from Rs. 7,289.16 Lakhs YoY.
  • Half-year ended September 30, 2026, standalone net profit was Rs. 21,163.23 Lakhs.
  • Standalone revenue from operations for Q2 FY27 stood at Rs. 33,008.55 Lakhs.
  • The Board of Directors approved the unaudited standalone and consolidated financial results on October 27, 2026.
  • The statutory auditors, M/s. Maheshwari & Co., issued a 'Limited Review Report' with no modifications.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Standalone Revenue from operations (Q2 FY27)
33,008.55 Lakhs
8.16
Standalone Profit for the period (Q2 FY27)
8,573.85 Lakhs
17.63
Standalone Revenue from operations (H1 FY27)
75,505.77 Lakhs
Not comparable — limited prior period data.
Standalone Profit for the period (H1 FY27)
21,163.23 Lakhs
79.91
Cash and cash equivalents (Sep 30, 2026)
26,337.16 Lakhs
64.57
Basic EPS (Q2 FY27)
16.58
86.29
🏢 How This Affects the Company
📈
Business Impact
The increase in revenue from operations for Q2 FY27 to Rs. 33,008.55 Lakhs indicates ongoing business activity in its Custom Synthesis and Speciality Chemicals segment.
💰
Financial Impact
Net profit for Q2 FY27 grew to Rs. 8,573.85 Lakhs, while cash and cash equivalents increased to Rs. 26,337.16 Lakhs as of September 30, 2026, strengthening liquidity.
⚙️
Operational Impact
The company continues to operate in a single segment, Custom Synthesis and manufacturing of Speciality Chemicals, as stated in the notes to the financial results.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected as these results reflect the company's financial performance. The diluted Earnings Per Share increased to Rs. 16.53 in Q2 FY27 from Rs. 8.90 in Q2 FY26.
🔍
Management Signal
The Board's approval of the unaudited results, after Audit Committee recommendation, indicates a focus on regular financial reporting and compliance with SEBI regulations.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q3 FY27 financial results – observe sustained revenue and profit trends.
Any updates on expansion or new projects in speciality chemicals segment.
Publication of audited annual financial results for FY27.
LOW RISK Limited risks are flagged; auditors provided an unmodified limited review report.
💡 Investor Takeaway
Acutaas Chemicals' standalone net profit for Q2 FY27 was Rs. 8,573.85 Lakhs, an increase of 17.63% from Rs. 7,289.16 Lakhs in Q2 FY26. Half-year net profit reached Rs. 21,163.23 Lakhs. Revenue from operations for Q2 FY27 was Rs. 33,008.55 Lakhs.
⚖️ Strengths & Concerns

✅ Positives

  • Standalone net profit for Q2 FY27 increased to Rs. 8,573.85 Lakhs from Rs. 7,289.16 Lakhs in Q2 FY26, showing a 17.63% YoY growth.
  • Cash and cash equivalents grew to Rs. 26,337.16 Lakhs as of September 30, 2026, compared to Rs. 16,004.18 Lakhs at the beginning of the year.

⚠️ Concerns

  • Standalone Revenue from operations for the half year ended September 30, 2026, was Rs. 75,505.77 Lakhs, compared to Rs. 51,116.43 Lakhs in the prior half year, which is not fully comparable given differing quarter starts.
  • Trade receivables stood at Rs. 35,247.20 Lakhs as of September 30, 2026, a slight decrease from Rs. 36,017.91 Lakhs as of March 31, 2026.
📅 Company Track Record
Acutaas Chemicals (formerly Ami Organics Limited) reported Q1 FY27 consolidated net profit of Rs. 7,497.24 lakhs, up 68.30% YoY. The company recommended a Rs. 2.5/share dividend on 8,18,71,122 shares for FY26.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Acutaas Chemicals' standalone net profit for the quarter ended September 30, 2026?
Acutaas Chemicals reported a standalone net profit of Rs. 8,573.85 Lakhs for the quarter ended September 30, 2026, an increase from Rs. 7,289.16 Lakhs in the prior year comparable period.
What was Acutaas Chemicals' standalone revenue from operations in Q2 FY27?
The standalone revenue from operations for Acutaas Chemicals for Q2 FY27 (quarter ended September 30, 2026) was Rs. 33,008.55 Lakhs.
What was Acutaas Chemicals' standalone net profit for the half year ended September 30, 2026?
For the half year ended September 30, 2026, Acutaas Chemicals reported a standalone net profit of Rs. 21,163.23 Lakhs, compared to Rs. 11,753.78 Lakhs for the half year ended September 30, 2025.
What was the Cash and cash equivalents balance for Acutaas Chemicals as of September 30, 2026?
As of September 30, 2026, Acutaas Chemicals had Cash and cash equivalents of Rs. 26,337.16 Lakhs.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.